RT期刊文章SR电子T1的菌血症发生率后支气管内超声引导针transbronchial愿望摩根富林明欧洲呼吸杂志乔和J FD欧元欧洲呼吸学会SP 28 OP 32做10.1183/09031936.00151809 VO 36是1 A1 Steinfort, D.P. A1约翰逊,测向A1欧文,188bet官网地址L.B. YR . 2010 UL //www.qdcxjkg.com/content/36/1/28.abstract AB关于超声引导下经支气管针吸(EBUS-TBNA)可能的感染性并发症的数据很少。目前的前瞻性评估是为了确定与EBUS-TBNA相关的菌血症和感染并发症的发生率。我们对连续接受EBUS-TBNA评估纵隔或肺门淋巴结病变的患者进行了研究。在TBNA后60秒内行静脉切开术进行有氧和无氧血液培养。同时对TBNA针进行无菌生理盐水冲洗。立即对血培养阳性的患者进行复查，所有患者在EBUS-TBNA治疗1周内进行临床复查。共有43例患者接受了EBUS-TBNA治疗，其中3例(7%)出现了菌血症。所有分离菌均为典型的口咽共生菌。15例(35%)患者TBNA洗针培养阳性。 None of the three bacteraemic patients had clinical features suggestive of infection, and no complications were seen among the cohort. The incidence of bacteraemia following EBUS-TBNA is comparable to that following routine flexible bronchoscopy. Performance of TBNA does not appear to measurably increase the risk of bacteraemia over that associated with insertion of the bronchoscope into the airway. Contamination of the TBNA needle with oropharyngeal commensal bacteria is common; however, clinically significant infection following EBUS-TBNA appears rare.